Strictly informational content: before starting any therapy, including natural ones, a consultation with an Ophthalmologist is essential.
In the approach of Systemic Ophthalmology and Eye Longevity, dry eye (Dry Eye Disease - DED) is studied as a condition in which the ocular surface, lacrimal glands, and Meibomian glands may be affected by systemic factors such as low-grade inflammation, oxidative stress, and metabolic alterations. Lubricating eye drops remain the validated first-line treatment according to clinical guidelines; the systemic approach studies possible contextual factors, alongside and not replacing prescribed ophthalmic therapy. This page is purely informative and does not replace a personalized ophthalmological evaluation.
The ocular surface and possible systemic contextual factors.
Not all artificial tears are equal. Some preservative-free formulations integrate naturally derived substances studied for possible soothing, osmoprotective or epithelial-support actions. Examples include osmoprotective molecules and vitamin components. Available evidence on these formulations varies; the choice must be individualized and agreed with the Ophthalmologist, especially in cases of known allergies or intolerances.
Nutrients and microbiota studied as a possible supportive context for ocular surface health.
Dry eye, blepharitis, and chalazion often share a common basis of Meibomian gland dysfunction and ocular surface inflammation. Therefore, in clinical pathways eyelid hygiene, dry eye management, and the prevention of blepharitis and recurrent chalazia are frequently assessed together.
The information provided here is general and does not replace a personalized therapeutic plan. Every remedy must be discussed with the Ophthalmologist before being started.
In our ophthalmology practice in Ravenna and Faenza, dry eye is evaluated with an integrated approach, combining validated ophthalmic therapy with any nutritional and systemic support agreed upon with the patient within the specialist pathway.